Free Trial

Chill Brands Group (CHLL) Competitors

Chill Brands Group logo
GBX 1.90 -0.10 (-5.00%)
As of 09/12/2025 11:43 AM Eastern

CHLL vs. PXS, MXC, RGT, CEL, N4P, HELD, HLN, HIK, INDV, and HCM

Should you be buying Chill Brands Group stock or one of its competitors? The main competitors of Chill Brands Group include Provexis (PXS), Argent BioPharma (MXC), Argent BioPharma (RGT), Celadon Pharmaceuticals (CEL), N4 Pharma (N4P), Hellenic Dynamics (HELD), Haleon (HLN), Hikma Pharmaceuticals (HIK), Indivior (INDV), and HUTCHMED (HCM). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Chill Brands Group vs. Its Competitors

Chill Brands Group (LON:CHLL) and Provexis (LON:PXS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Provexis has higher revenue and earnings than Chill Brands Group. Provexis is trading at a lower price-to-earnings ratio than Chill Brands Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chill Brands Group£305.70K31.47-£3.64M-£0.01-292.31
Provexis£1.20M12.51-£619.15K-£0.00-2,133.33

Chill Brands Group has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Provexis' return on equity of -68.68% beat Chill Brands Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Chill Brands GroupN/A -2,802.21% -44.64%
Provexis -73.10%-68.68%-56.14%

Chill Brands Group has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Provexis has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500.

1.5% of Chill Brands Group shares are held by institutional investors. Comparatively, 7.9% of Provexis shares are held by institutional investors. 10.7% of Chill Brands Group shares are held by insiders. Comparatively, 11.8% of Provexis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Chill Brands Group had 2 more articles in the media than Provexis. MarketBeat recorded 3 mentions for Chill Brands Group and 1 mentions for Provexis. Chill Brands Group's average media sentiment score of 0.18 beat Provexis' score of 0.00 indicating that Chill Brands Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Chill Brands Group
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Provexis
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Provexis beats Chill Brands Group on 7 of the 13 factors compared between the two stocks.

Get Chill Brands Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHLL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHLL vs. The Competition

MetricChill Brands GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£9.62M£1.68B£5.86B£2.58B
Dividend YieldN/A2.93%5.68%5.30%
P/E Ratio-292.3165.3974.525,410.66
Price / Sales31.471,297.60547.6296,691.08
Price / Cash11.5010.3737.5627.93
Price / BookN/A11.9112.167.76
Net Income-£3.64M£20.70B£3.28B£5.89B
7 Day Performance10.34%0.72%0.87%6.47%
1 Month Performance62.39%1.71%4.96%55.90%
1 Year PerformanceN/A4.78%60.75%147.79%

Chill Brands Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHLL
Chill Brands Group
N/AGBX 1.90
-5.0%
N/AN/A£9.62M£305.70K-292.317
PXS
Provexis
N/AGBX 0.78
+6.1%
N/A-7.2%£18.30M£1.20M-2,600.004News Coverage
Gap Up
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32M-13.255Gap Up
RGT
Argent BioPharma
N/AN/AN/AN/A£8.31MN/A-0.65N/AGap Down
High Trading Volume
CEL
Celadon Pharmaceuticals
N/AGBX 13.40
flat
N/AN/A£8.22M£123.38K-1.682,780Positive News
N4P
N4 Pharma
N/AGBX 0.60
+4.3%
N/A-9.1%£4.99M£7.28K-193.555Gap Up
High Trading Volume
HELD
Hellenic Dynamics
N/AGBX 0.01
flat
N/AN/A£14KN/A0.00N/A
HLN
Haleon
1.8774 of 5 stars
GBX 367.20
-0.9%
GBX 435
+18.5%
-6.4%£32.99B£11.02B2,198.8025,408News Coverage
Analyst Forecast
HIK
Hikma Pharmaceuticals
3.5998 of 5 stars
GBX 1,723
-1.0%
GBX 2,627.50
+52.5%
-15.4%£3.80B£3.22B1,070.199,100Negative News
INDV
Indivior
2.1185 of 5 stars
GBX 1,238
+1.6%
GBX 1,650
+33.3%
+70.4%£1.93B£1.40B-1,026.481,000Gap Up
High Trading Volume
HCM
HUTCHMED
N/AGBX 215
-5.5%
N/A+2.0%£1.84B£602.20M5,375.001,760News Coverage
Positive News
Gap Down

Related Companies and Tools


This page (LON:CHLL) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners